| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 345.32K | 57.34K | 3.79K | 0.00 | 14.00M | 2.00M |
| Gross Profit | -2.83M | -3.87M | -12.22K | 0.00 | 12.40M | 1.20M |
| EBITDA | -23.27M | -46.21M | -24.11M | -26.32M | -12.17M | -19.69M |
| Net Income | -25.50M | -49.82M | -27.26M | -28.01M | -12.78M | -19.77M |
Balance Sheet | ||||||
| Total Assets | 82.79M | 3.67M | 28.78M | 31.04M | 31.66M | 33.91M |
| Cash, Cash Equivalents and Short-Term Investments | 8.22M | 2.12M | 14.85M | 22.86M | 19.46M | 28.37M |
| Total Debt | 8.49M | 11.24M | 16.08M | 10.12M | 7.15M | 463.35K |
| Total Liabilities | 12.03M | 16.76M | 19.78M | 13.80M | 11.19M | 18.60M |
| Stockholders Equity | 70.76M | -13.10M | 9.00M | 17.23M | 20.47M | 15.30M |
Cash Flow | ||||||
| Free Cash Flow | -62.32M | -30.28M | -27.81M | -25.98M | -22.49M | -6.65M |
| Operating Cash Flow | -16.82M | -30.12M | -23.84M | -25.11M | -20.87M | -6.38M |
| Investing Cash Flow | -65.64M | -161.48K | -3.97M | -874.75K | -1.62M | -261.26K |
| Financing Cash Flow | 83.49M | 17.55M | 19.79M | 21.51M | 21.46M | 20.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $62.58M | -20.52 | -5.71% | ― | -13.79% | -132.21% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | $33.34M | -0.17 | -68.49% | ― | 984.82% | 63.54% | |
45 Neutral | $45.01M | -2.58 | -157.91% | ― | -18.96% | 8.98% | |
44 Neutral | $48.11M | -3.68 | -96.15% | ― | -8.97% | 47.29% | |
44 Neutral | $50.76M | -1.29 | ― | ― | 12.24% | 47.45% |
Hyperion DeFi has updated its risk factors, highlighting the volatility and risks associated with its HYPE token and treasury strategy. The company acknowledges the potential for significant financial impact due to the fluctuating value of HYPE, regulatory uncertainties, and technological challenges. The release outlines various risks, including market volatility, regulatory scrutiny, and technological vulnerabilities, which could affect the company’s financial condition and stock value. The company also notes the competitive landscape and the potential for emerging technologies to impact the demand for HYPE.
On November 14, 2025, Hyperion DeFi, Inc. entered into a Sales Agreement with Cantor Fitzgerald & Co. and Chardan Capital Markets, LLC, allowing the company to offer and sell shares of its common stock through these sales agents. The agreement permits the company to sell shares with an aggregate offering price of up to $500 million, with sales executed in various transaction types, including block trades and at-the-market offerings. The sales agents will earn a 4% commission on the gross sales proceeds, and the offering will terminate upon the sale of all shares or termination of the agreement. This move is expected to impact Hyperion DeFi’s market positioning by potentially increasing its capital for further expansion and operations.
On November 13, 2025, Hyperion DeFi announced its third-quarter financial results for the period ending September 30, 2025, reporting a record net income of $6.6 million. The company has undergone a significant transformation, pivoting from ophthalmic technology to becoming a leading institutional gateway for DeFi innovation. The company’s new digital asset treasury strategy has led to substantial financial growth, with revenue increasing from $1,625 in Q3 2024 to $302,506 in Q3 2025. Hyperion DeFi has also launched a co-brand validator, ‘Kinetiq x Hyperion,’ and has seen a 60% month-over-month increase in staked HYPE tokens. The company anticipates continued growth with positive operating cash flows expected in 2026.
On October 27, 2025, Hyperion DeFi entered a Joint Validator Agreement with Kinetiq Research and Pier Two to operate a co-branded validator node on the Hyperliquid blockchain, effective retroactively from June 25, 2025. This agreement involves shared responsibilities and revenue-sharing arrangements, enhancing Hyperion’s operational capacity and market positioning in blockchain validation. Additionally, Hyperion announced a strategic partnership with Felix to launch a perpetual futures market on the Hyperliquid protocol, leveraging 500,000 HYPE tokens. This partnership aims to expand Hyperliquid’s product suite and revenue streams, marking a significant step in decentralized finance innovation.
On September 30, 2025, Michael Rowe resigned from the Board of Directors of Hyperion DeFi, Inc. This departure may impact the company’s governance and strategic direction.
On September 29, 2025, Hyperion DeFi announced the appointment of David Knox as Chief Financial Officer, marking a strategic move to enhance governance and accelerate its decentralized finance strategy. Knox, who previously held significant roles at PayPal and SoFi, brings extensive expertise in capital markets and financial services, and aims to position Hyperion DeFi as a bridge between traditional finance and the decentralized future, driving value for the ecosystem and shareholders.
On September 24, 2025, Hyperion DeFi, Inc. amended its sales agreement with Chardan Capital Markets, increasing its at-the-market offering program from $50 million to $100 million. As of this date, the company has sold over 4 million shares, generating approximately $29 million in net proceeds, enhancing its liquidity and market presence.